The RSC Nucleic Acids Group invites you to their Forum meeting, which will take place in-person at the RSC's iconic Burlington House in London. This is the NAG’s annual meeting, bringing together the ...

Nucleic-acid therapeutics articles from across Nature Portfolio Nucleic acid therapeutics are based on nucleic acids or closely related chemical compounds. They include antisense oligonucleotides ...

By sensing viral nucleic acids and producing type I interferons, plasmacytoid dendritic cells (pDCs) are key mediators of antiviral immunity. But pDCs might also contribute to autoimmune disease ...

Researchers at the University of Oxford and Nanyang Technological University, Singapore (NTU Singapore) have uncovered the mechanism by which cells identify and repair a highly toxic form of DNA ...

What made ribose the sugar of choice for life's code? Scientists at Scripps Research may have cracked a major part of this ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

Nucleic acid therapeutics (involving essentially the same molecule, differing only in length and sequence) are uniquely qualified for platform-based personalized production in local hospital ...

The NANOSPRESSO system has high potential to enable the point-of-care production of nucleic acid-loaded LNPs, bypassing the logistical and scalability limitations of centralized manufacturing. Its ...

Reactions involving the transfer of a phosphoryl (−PO32–) group are fundamental to cellular metabolism. These reactions are catalyzed by enzymes, often large and complex, belonging to the ...

Lloyd puts acid on Carlton's leadership group Essendon legend Matthew Lloyd calls into question Carlton's leadership group, including Patrick Cripps.